PTPN6 and hepatocellular carcinoma: Our work reported herein uncovered the mechanism of action (as illustrated in the graphical abstract) by which sorafenib triggers ferroptosis in HCC—via SHP-1/STAT3-regulated MCL1:BECN1 decoupling and the consequent BECN1:SLC7A11 coupling.